A novel human osteoblast-derived severe combined immunodeficiency mouse model of bone metastasis

Journal of Neurosurgery: Spine

Volumn 4, Issue 5, 2006, Pages 388-391

  Schuster, James ^a   Zhang, Jun ^b   Longo, Maria ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

Animal model; Metastasis; Mouse; Spinal tumor

Indexed keywords

COLLAGEN SPONGE; HYDROXYAPATITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MATURATION; BONE METASTASIS; CARCINOMA CELL; CELL SUSPENSION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOBLAST; SPINE METASTASIS; ANIMAL; BONE TUMOR; CANCER TRANSPLANTATION; CELL TRANSFORMATION; DISEASE MODEL; LUNG TUMOR; MALE; METASTASIS; MOUSE MUTANT; PATHOLOGY; PROSTATE TUMOR; SPINAL CORD TUMOR; TUMOR CELL LINE;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; OSTEOBLASTS; PROSTATIC NEOPLASMS; SPINAL NEOPLASMS;

EID: 33646912241     PISSN: 15475654     EISSN: None     Source Type: Journal    
DOI: 10.3171/spi.2006.4.5.388     Document Type: Article

References (18)

1. Blaszczyk N, Masri BA, Mawji NR, Ueda T, McAlinden G, Duncan CP, et al: Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells. Clin Cancer Res 10:1860-1869, 2004
2. Brown JM: In vivo models of human prostate cancer bone metastasis. Methods Mol Med 81:149-162, 2003
3. Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, et al: Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells. Prostate 52:20-33, 2002
4. Corey E, Quinn JE, Vessella RL: A novel method of generating prostate cancer metastases from orthotopic implants. Prostate 56:110-114, 2003
5. Eisenman J, Ahdieh M, Beers C, Brasel K, Kennedy MK, Le T, et al: Interleukin-15 interactions with interleukin-15 receptor complexes: characterization and species specificity. Cytokine 20:121-129, 2002
6. Helweg-Larsen S, Sorensen PS, Kreiner S: Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Oncol Biol Phys 46:1163-1169, 2000
7. Holleran JL, Miller CJ, Edgehouse NL, Pretlow TP, Culp LA: Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells. Clin Exp Metastasis 19:17-24, 2002
8. Ishikawa S, Soloway MS, Van der Zwaag R, Todd B: Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancer. J Urol 141:1139-1142, 1989
9. Krebsbach PH, Kuznetsov SA, Bianco P, Robey PG: Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med 10:165-181, 1999
10. Kuban DA, El-mahdi AM, Sigfred SV, Schellhammer PF, Babb TJ: Characteristics of spinal cord compression in adenocarcinoma of prostate. Urology 28:364-369, 1986
11. Kudo O, Sabokbar A, Pocock A, Itonaga I, Athanasou NA: Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts. Calcif Tissue Int 71:539-546, 2002
12. Liu KD, Greene WC, Goldsmith MA: The a chain of the IL-2 receptor determines the species specificity of high-affinity IL-2 binding. Cytokine 8:613-621, 1996
13. Mundy G: Preclinical models of bone metastases. Semin Oncol 28 (4 Suppl):2-8, 2001
14. Nemeth JA, Yousif R, Herzog M, Che M, Upadhyay J, Shekarriz B, et al: Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. J Natl Cancer Inst 94:17-25, 2002
15. Rosol TJ, Tannehill-Gregg SH, LeRoy BE, Mandl S, Contag CH: Animal models of bone metastasis. Cancer 97 (3 Suppl):748-757, 2003
16. Smith EM, Hampel N, Ruff RL, Bodner DR, Resnick MI: Spinal cord compression secondary to prostate carcinoma: treatment and prognosis. J Urol 149:330-333, 1993
17. Soloway MS: The importance of prognostic factors in advanced prostate cancer. Cancer 66 (5 Suppl):1017-1021, 1990
18. Soloway MS, Ishikawa S, van der Zwaag R, Todd B: Prognostic factors in patients with advanced prostate cancer. Urology 33 (5 Suppl):53-56, 1989